Evidence map›Paper›PMID 38952083›Full record

ArticleAnnals of clinical and translational neurology2024

DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease.

Viviana Torres, Jesica Pérez-Montesino, Rubén Fernández-Santiago, Manel Fernández, Ana Camara, Yaroslau Compta, María-José Martí, Àlex Guerra Beltran, José Rios, Francesc Valldeoriola and 1 more

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Brain-Behavior Relationships: Neural Mechanisms of Impulsivity and Compulsivity in Neuropsychiatric Disorders.Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2025
    Review
  3. Article
  4. Behavioral disorders in Parkinson disease: current view.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Viviana Torres *Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies UBNeuro, Hospital Clínic Universitari de Barcelona, Barcelona, Catalonia, Spain.ORCID 0000-0003-1795-0072
Jesica Pérez-Montesino *Lab of Parkinson's disease and other Neurodegenerative Movement Disorders: Clinical and Experimental Research, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, 08036, Catalonia, Spain.
Rubén Fernández-SantiagoLab of Parkinson's disease and other Neurodegenerative Movement Disorders: Clinical and Experimental Research, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, 08036, Catalonia, Spain.ORCID 0000-0002-4582-0702
Manel FernándezLab of Parkinson's disease and other Neurodegenerative Movement Disorders: Clinical and Experimental Research, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, 08036, Catalonia, Spain.
Ana CamaraParkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies UBNeuro, Hospital Clínic Universitari de Barcelona, Barcelona, Catalonia, Spain.
Yaroslau ComptaParkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies UBNeuro, Hospital Clínic Universitari de Barcelona, Barcelona, Catalonia, Spain.
María-José MartíParkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies UBNeuro, Hospital Clínic Universitari de Barcelona, Barcelona, Catalonia, Spain.
Àlex Guerra BeltranLab of Parkinson's disease and other Neurodegenerative Movement Disorders: Clinical and Experimental Research, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, 08036, Catalonia, Spain.
José RiosDepartment of Clinical Pharmacology, Hospital Clinic, and Medical Statistics Core Facility, Institutd'InvestigacionsBiomèdiques August Pi ISunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Francesc ValldeoriolaParkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociencies UBNeuro, Hospital Clínic Universitari de Barcelona, Barcelona, Catalonia, Spain.ORCID 0000-0002-8680-4274
Mario EzquerraLab of Parkinson's disease and other Neurodegenerative Movement Disorders: Clinical and Experimental Research, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, 08036, Catalonia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impulse control disorders and their consequences display variability among individuals, indicating potential involvement of environmental and genetic factors. In this retrospective study, we analyzed a cohort of Parkinson's disease patients treated with dopamine agonists and investigated the influence of the dopamine D4 receptor gene polymorphism, DRD4 7R+, which is linked to psychiatric disorders, impulsive traits, and addictive behaviors. We found that DRD4 7R+ is a significant genetic risk factor associated with the severity of ICD.

Indexed as

Disruptive, Impulse Control, and Conduct DisordersDopamine AgonistsParkinson DiseaseReceptors, Dopamine D4AgedFemaleHumansMaleMiddle AgedPolymorphism, GeneticRetrospective StudiesDopamine AgonistsDRD4 protein, humanReceptors, Dopamine D4

Identifiers

PMID38952083
PMCPMC11330210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.